CY1112852T1 - Μεθοδος προσδιορισμου της μεθυλιωσης dνα σε δειγματα αιματος ή ουρων - Google Patents
Μεθοδος προσδιορισμου της μεθυλιωσης dνα σε δειγματα αιματος ή ουρωνInfo
- Publication number
- CY1112852T1 CY1112852T1 CY20121100439T CY121100439T CY1112852T1 CY 1112852 T1 CY1112852 T1 CY 1112852T1 CY 20121100439 T CY20121100439 T CY 20121100439T CY 121100439 T CY121100439 T CY 121100439T CY 1112852 T1 CY1112852 T1 CY 1112852T1
- Authority
- CY
- Cyprus
- Prior art keywords
- dna
- remote sample
- methods
- compositions
- dynahylation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2523/00—Reactions characterised by treatment of reaction samples
- C12Q2523/10—Characterised by chemical treatment
- C12Q2523/125—Bisulfite(s)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pathology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- General Chemical & Material Sciences (AREA)
Abstract
Εκδοχές της παρούσας εφεύρεσης σχετίζονται με συνθέσεις και μεθόδους αποκόμισης θραυσμάτων DΝΑ από ένα εξωτερικό δείγμα. Σε συγκεκριμένες εκδοχές αποκομίζεται ένα εξωτερικό δείγμα που περιέχει DΝΑ, το DΝΑ απομονώνεται από το εξωτερικό δείγμα και το απομονωμένο DΝΑ κατεργάζεται κατά τρόπο που επιτρέπει διαφοροποίηση της μεθυλιωμένης από τη μη μεθυλιωμένη κυτοσίνη. Επιπρόσθετες, συγκεκριμένες υλοποιήσεις παρέχουν συνθέσεις και μεθόδους ανάλυσης της μεθυλίωσης του DΝΑ ενός εξωτερικού δείγματος. Άλλες εκδοχές παρέχουν συνθέσεις και μεθόδους ενίσχυσης όλου του γενώματος DΝΑ κατεργασμένου με όξινο θειώδες.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US67224205P | 2005-04-15 | 2005-04-15 | |
US67699705P | 2005-05-02 | 2005-05-02 | |
US69752105P | 2005-07-08 | 2005-07-08 | |
US72360205P | 2005-10-04 | 2005-10-04 | |
US78024806P | 2006-03-08 | 2006-03-08 | |
EP06750657A EP1871912B1 (en) | 2005-04-15 | 2006-04-17 | Method for determining DNA methylation in blood or urine samples |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1112852T1 true CY1112852T1 (el) | 2016-02-10 |
Family
ID=36808881
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20121100439T CY1112852T1 (el) | 2005-04-15 | 2012-05-11 | Μεθοδος προσδιορισμου της μεθυλιωσης dνα σε δειγματα αιματος ή ουρων |
Country Status (13)
Country | Link |
---|---|
US (1) | US10731215B2 (el) |
EP (2) | EP2481810A1 (el) |
JP (2) | JP5133238B2 (el) |
AT (1) | ATE547537T1 (el) |
AU (1) | AU2006236363B2 (el) |
CA (1) | CA2603815C (el) |
CY (1) | CY1112852T1 (el) |
DK (1) | DK1871912T3 (el) |
ES (1) | ES2382746T3 (el) |
PL (1) | PL1871912T3 (el) |
PT (1) | PT1871912E (el) |
SI (1) | SI1871912T1 (el) |
WO (1) | WO2006113770A1 (el) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4714148B2 (ja) | 2003-09-04 | 2011-06-29 | ヒューマン ジェネティック シグネチャーズ ピーティーワイ リミテッド | 核酸検出アッセイ |
BRPI0517131B1 (pt) | 2004-12-03 | 2021-08-31 | Human Genetic Signatures Pty Ltd | Métodos para simplificar ácidos nucléicos microbiais por modificação química de citosinas |
WO2007030882A1 (en) | 2005-09-14 | 2007-03-22 | Human Genetic Signatures Pty Ltd | Assay for a health state |
GB0700374D0 (en) | 2007-01-09 | 2007-02-14 | Oncomethylome Sciences S A | NDRG family methylation markers |
WO2008135512A2 (en) * | 2007-05-02 | 2008-11-13 | Jerzy Paszkowski | Dna amplification method |
DK2479289T3 (en) | 2007-06-08 | 2016-05-02 | Epigenomics Ag | Method for methylation analysis |
CA2706740C (en) * | 2007-11-27 | 2017-01-17 | Human Genetic Signatures Pty Ltd | Enzymes for amplification and copying bisulphite modified nucleic acids |
EP2071035A1 (en) | 2007-12-13 | 2009-06-17 | Epigenomics AG | Facilitator and method for amplification |
WO2010037001A2 (en) | 2008-09-26 | 2010-04-01 | Immune Disease Institute, Inc. | Selective oxidation of 5-methylcytosine by tet-family proteins |
EP2362910A4 (en) * | 2008-11-03 | 2012-05-09 | Alchemy Biosciences Pty Ltd | METHOD FOR DNA CLONING |
EP2189538A1 (en) | 2008-11-21 | 2010-05-26 | Epigenomics AG | An analysis molecule and method for the analysis of a nucleotide position in a nucleic acid |
US9234456B2 (en) | 2009-10-06 | 2016-01-12 | Cummins Ltd. | Turbomachine |
WO2011135058A2 (en) | 2010-04-30 | 2011-11-03 | Mdxhealth Sa | Methods for detecting epigenetic modifications |
GB201105726D0 (en) | 2011-04-04 | 2011-05-18 | Cummins Ltd | A turbine |
US10140420B2 (en) * | 2011-10-12 | 2018-11-27 | Merge Healthcare Incorporation | Systems and methods for independent assessment of image data |
EP3425065B1 (en) | 2011-12-13 | 2021-04-21 | Oslo Universitetssykehus HF | Methods and kits for detection of methylation status |
US10563248B2 (en) | 2012-11-30 | 2020-02-18 | Cambridge Epigenetix Limited | Oxidizing agent for modified nucleotides |
US10203346B2 (en) * | 2013-10-22 | 2019-02-12 | Hitachi High-Technologies Corporation | Automatic analysis device |
WO2017059245A2 (en) | 2015-09-30 | 2017-04-06 | Trustees Of Boston University | Deadman and passcode microbial kill switches |
EP3998353A1 (en) | 2015-10-30 | 2022-05-18 | Exact Sciences Corporation | Multiplex amplification detection assay and isolation and detection of dna from plasma |
KR102436270B1 (ko) | 2016-05-05 | 2022-08-25 | 이그젝트 싸이언스 디블롭먼트 컴패니, 엘엘씨 | 메틸화된 dna 분석에 의한 폐 종양의 검출 |
CN109642227B (zh) * | 2016-07-19 | 2023-02-28 | 精密科学发展有限责任公司 | 来自非人类生物体的核酸对照分子 |
CA3049459A1 (en) | 2017-01-27 | 2018-08-02 | Exact Sciences Development Company, Llc | Detection of colon neoplasia by analysis of methylated dna |
CA3060555A1 (en) | 2017-04-19 | 2018-10-25 | Singlera Genomics, Inc. | Compositions and methods for library construction and sequence analysis |
CN107058553A (zh) * | 2017-05-05 | 2017-08-18 | 武汉爱基百客生物科技有限公司 | 一种分子ssr标记技术 |
US10648025B2 (en) | 2017-12-13 | 2020-05-12 | Exact Sciences Development Company, Llc | Multiplex amplification detection assay II |
EP3765637A1 (en) | 2018-03-13 | 2021-01-20 | Grail, Inc. | Anomalous fragment detection and classification |
CN116323977A (zh) | 2020-07-30 | 2023-06-23 | 剑桥表现遗传学有限公司 | 用于核酸分析的组合物和方法 |
CN112708546B (zh) * | 2021-01-13 | 2023-11-07 | 苏州缔因安生物科技有限公司 | 一种全集成核酸即时检测装置及其应用 |
US11332777B1 (en) * | 2021-10-28 | 2022-05-17 | URIT Medical Electronic Co., Ltd. | Methods and reagent kits for bisulfite conversion of DNA |
Family Cites Families (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2136092T3 (es) * | 1991-09-23 | 1999-11-16 | Medical Res Council | Procedimientos para la produccion de anticuerpos humanizados. |
US5532127A (en) * | 1992-01-27 | 1996-07-02 | Icos Corporation | Assay for 1-CAM related protein expression |
US5786146A (en) * | 1996-06-03 | 1998-07-28 | The Johns Hopkins University School Of Medicine | Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids |
WO1998056952A1 (en) | 1997-06-09 | 1998-12-17 | University Of Southern California | A cancer diagnostic method based upon dna methylation differences |
US6124120A (en) | 1997-10-08 | 2000-09-26 | Yale University | Multiple displacement amplification |
US6818404B2 (en) * | 1997-10-23 | 2004-11-16 | Exact Sciences Corporation | Methods for detecting hypermethylated nucleic acid in heterogeneous biological samples |
DE19754482A1 (de) | 1997-11-27 | 1999-07-01 | Epigenomics Gmbh | Verfahren zur Herstellung komplexer DNA-Methylierungs-Fingerabdrücke |
GB9812768D0 (en) | 1998-06-13 | 1998-08-12 | Zeneca Ltd | Methods |
WO2000050564A2 (en) * | 1999-02-26 | 2000-08-31 | Myriad Genetics, Inc. | Method for extracting dna from dried specimens |
US6277607B1 (en) | 1999-05-24 | 2001-08-21 | Sanjay Tyagi | High specificity primers, amplification methods and kits |
US6709818B1 (en) * | 1999-10-13 | 2004-03-23 | The Johns Hopkins University School Of Medicine | Methods of diagnosing and treating hepatic cell proliferative disorders |
DE19957827C2 (de) | 1999-11-25 | 2003-06-12 | Epigenomics Ag | Verwendung eines Oligomer-Arrays mit PNA- und/oder DNA-Oligomeren auf einer Oberfläche |
US7611869B2 (en) * | 2000-02-07 | 2009-11-03 | Illumina, Inc. | Multiplexed methylation detection methods |
DE10010280B4 (de) | 2000-02-25 | 2006-08-10 | Epigenomics Ag | Verfahren zur Detektion von Cytosin-Methylierung in DNA Proben |
DE10010281B4 (de) | 2000-02-25 | 2005-03-10 | Epigenomics Ag | Ligase/Polymerase-Verfahren zur Detektion von Cytosin-Methylierung in DNA Proben |
DE10010282B4 (de) | 2000-02-25 | 2006-11-16 | Epigenomics Ag | Verfahren zur Detektion von Cytosin-Methylierung in DNA Proben |
JP2004507214A (ja) | 2000-03-15 | 2004-03-11 | エピゲノミクス アーゲー | 腫瘍抑制遺伝子と腫瘍遺伝子に関連する疾患の診断 |
DE10019058A1 (de) | 2000-04-06 | 2001-12-20 | Epigenomics Ag | Detektion von Variationen des DNA-Methylierungsprofils |
DE10032529A1 (de) | 2000-06-30 | 2002-02-07 | Epigenomics Ag | Diagnose von bedeutenden genetischen Parametern innerhalb des Major Histocompatibility Complex (MHC) |
DE20121973U1 (de) | 2000-03-15 | 2003-12-24 | Epigenomics Ag | Nukleinsäuren für die Diagnose von mit dem Zellzyklus assoziierten Krankheiten |
DE10013847A1 (de) | 2000-03-15 | 2001-09-27 | Epigenomics Ag | Oligonukleotide oder PNA-Oligomere und Verfahren zur parallelen Detektion des Methylierungszustandes genomischer DNA |
DE20121977U1 (de) | 2000-03-15 | 2003-12-24 | Epigenomics Ag | Nukleinsäuren für die Diagnose von mit Tumor-Suppressorgenen und Onkogenen assoziierten Krankheiten |
DE20121969U1 (de) | 2000-04-06 | 2003-12-24 | Epigenomics Ag | Nukleinsäuren für die Diagnose von mit DNA Reparatur assoziierten Krankheiten |
DE20121968U1 (de) | 2000-04-06 | 2003-12-18 | Epigenomics Ag | Nukleinsäuren für die Diagnose von mit Apoptose assoziierten Krankheiten |
AU2001277487A1 (en) | 2000-04-06 | 2001-10-23 | Epigenomics Ag | Diagnosis of diseases associated with metabolism |
DE20121972U1 (de) | 2000-04-06 | 2003-12-24 | Epigenomics Ag | Nukleinsäuren für die Diagnose von mit DNA Transkription assoziierten Krankheiten |
DE20121964U1 (de) | 2000-04-06 | 2004-01-15 | Epigenomics Ag | Nukleinsäuren für die Diagnose von mit dem Metabolismus assoziierten Krankheiten |
DE20121965U1 (de) | 2000-04-06 | 2003-12-24 | Epigenomics Ag | Nukleinsäuren für die Diagnose von mit DNA Addukten assoziierten Krankheiten |
DE20121960U1 (de) | 2000-04-06 | 2004-01-15 | Epigenomics Ag | Nukleinsäuren für die Diagnose von mit Metastase assoziierten Krankheiten |
DE20121974U1 (de) | 2000-04-06 | 2003-12-24 | Epigenomics Ag | Nukleinsäuren für die Diagnose von mit DNA Replikation assoziierten Krankheiten |
DE20121970U1 (de) | 2000-04-06 | 2003-12-24 | Epigenomics Ag | Nukleinsäuren für die Diagnose von mit der Genregulation assoziierten Krankheiten |
DE10029915B4 (de) | 2000-06-19 | 2005-06-16 | Epigenomics Ag | Verfahren zum Nachweis von Cytosin-Methylierungen |
DE20121963U1 (de) | 2000-06-30 | 2003-12-18 | Epigenomics Ag | Nukleinsäuren für die Diagnose von mit Entwicklungsgenen assoziierten Krankheiten |
DE20121966U1 (de) | 2000-06-30 | 2003-11-20 | Epigenomics AG, 10435 Berlin | Nukleinsäuren für die Diagnose von mit dem Immunsystem assoziierten Krankheiten |
DE20121979U1 (de) | 2000-06-30 | 2003-12-24 | Epigenomics Ag | Nukleinsäuren für die Diagnose von mit der Zellsignalisierung assoziierten Krankheiten |
DE20121961U1 (de) | 2000-06-30 | 2003-12-18 | Epigenomics Ag | Nukleinsäuren für die Diagnose von mit der Signaltransduktion assoziierten Krankheiten |
WO2002002807A2 (en) | 2000-06-30 | 2002-01-10 | Epigenomics Ag | Diagnosis of diseases associated with cell signalling |
DE20121975U1 (de) | 2000-06-30 | 2004-01-15 | Epigenomics Ag | Nukleinsäuren für die Differenzierung von Astrocytomen, Oligoastrocytomen und Oligodendrogliom-Tumorzellen |
DE20121967U1 (de) | 2000-06-30 | 2003-12-18 | Epigenomics Ag | Nukleinsäuren für die Diagnose von Verhaltensstörungen, neurologischen Erkrankungen und Krebs |
DE20121978U1 (de) | 2000-06-30 | 2004-01-15 | Epigenomics Ag | Nukleinsäuren für die Analyse von Astrocytomen |
DE20121971U1 (de) | 2000-06-30 | 2003-12-24 | Epigenomics Ag | Nukleinsäuren für die Pharmakogenomische Methylierungsanalyse |
DE10037769A1 (de) | 2000-08-03 | 2002-02-21 | Epigenomics Gmbh | Diagnose von mit CD24 assoziierten Krankheiten |
EP1352089B1 (en) | 2000-08-25 | 2006-12-06 | Lovelace Respiratory Research Institute | Nested methylation-specific polymerase chain reaction cancer detection method |
DE50113454D1 (de) | 2000-09-01 | 2008-02-14 | Epigenomics Ag | Verfahren zur bestimmung des methylierungsgrades von bestimmten cytosinen in genomischer dna im sequenzkontext 5'-cpg-3' |
AU2002224328A1 (en) * | 2000-09-20 | 2002-04-02 | Case Western Reserve University | Methods and compositions for detecting cancers associated with methylation of hmlh1promoter dna |
DE10054972A1 (de) | 2000-11-06 | 2002-06-06 | Epigenomics Ag | Diagnose von mit humos assoziierten Krankheiten |
DE10054974A1 (de) | 2000-11-06 | 2002-06-06 | Epigenomics Ag | Diagnose von mit Cdk4 assoziierten Krankheiten |
DE10061338A1 (de) | 2000-12-06 | 2002-06-20 | Epigenomics Ag | Diagnose von mit Angiogenese assoziierten Krankheiten |
DE10112515B4 (de) | 2001-03-09 | 2004-02-12 | Epigenomics Ag | Verfahren zum Nachweis von Cytosin-Methylierungsmustern mit hoher Sensitivität |
WO2002077895A2 (en) | 2001-03-26 | 2002-10-03 | Epigenomics Ag | Method for epigenetic feature selection |
US6803216B2 (en) * | 2001-05-30 | 2004-10-12 | Stratagene California | Compositions and methods for random nucleic acid mutagenesis |
DE10128508A1 (de) | 2001-06-14 | 2003-02-06 | Epigenomics Ag | Verfahren und Nukleinsäuren für die Differenzierung von Prostata-Tumoren |
DE10130800B4 (de) | 2001-06-22 | 2005-06-23 | Epigenomics Ag | Verfahren zum Nachweis von Cytosin-Methylierung mit hoher Sensitivität |
DE10139283A1 (de) | 2001-08-09 | 2003-03-13 | Epigenomics Ag | Verfahren und Nukleinsäuren zur Analyse von Colon-Krebs |
US6927028B2 (en) | 2001-08-31 | 2005-08-09 | Chinese University Of Hong Kong | Non-invasive methods for detecting non-host DNA in a host using epigenetic differences between the host and non-host DNA |
WO2003027259A2 (en) * | 2001-09-26 | 2003-04-03 | Epigenx Pharmaceuticals, Inc. | Assays for dna methylation changes |
DE10164501A1 (de) | 2001-11-23 | 2003-06-12 | Epigenomics Ag | Verfahren und Nukleinsäuren für die Analyse einer Lymphoid-Zellteilungsstörung |
EP1451354A2 (en) | 2001-11-23 | 2004-09-01 | Epigenomics AG | Method and nucleic acids for the analysis of a lymphoid cell proliferative disorder |
DE10161625A1 (de) | 2001-12-14 | 2003-07-10 | Epigenomics Ag | Verfahren und Nukleinsäuren für die Analyse einer Lungenzell-Zellteilungsstörung |
AU2003212878A1 (en) * | 2002-01-30 | 2003-09-02 | Epigenomics Ag | Identification of cell differentiation states based on methylation patterns |
EP1340818A1 (en) | 2002-02-27 | 2003-09-03 | Epigenomics AG | Method and nucleic acids for the analysis of a colon cell proliferative disorder |
AU2003223041A1 (en) * | 2002-04-09 | 2003-10-20 | Epigenomics Ag | Method for analysis of methylated nucleic acids |
EP1369493B1 (de) | 2002-06-05 | 2006-09-13 | Epigenomics AG | Verfahren zur quantitiven Bestimmung des Methylierungsgrades von Cytosinen in CpG-Positionen |
DE10230692A1 (de) | 2002-07-08 | 2004-02-12 | Epigenomics Ag | Verfahren und Nukleinsäuren für die Analyse von Methylierungsmustern innerhalb des DD3-Gens |
DE10255104A1 (de) | 2002-08-27 | 2004-03-11 | Epigenomics Ag | Verfahren und Nukleinsäuren für die Analyse von proliferativen Erkrankungen von Brustzellen |
DE10245779A1 (de) | 2002-10-01 | 2004-04-29 | Epigenomics Ag | Verfahren und Nukleinsäuren für die verbesserte Behandlung von proliferativen Erkrankungen von Brustzellen |
US8101359B2 (en) | 2002-10-01 | 2012-01-24 | Epigenomics Ag | Method for determining risk of relapse of breast cancer following tamoxifen adjuvant therapy |
EP2418287B1 (en) * | 2002-10-11 | 2013-09-18 | Erasmus Universiteit Rotterdam | Nucleic acid amplification primers for PCR-based clonality studies of the TCR-beta gene |
CA2520811C (en) * | 2003-03-28 | 2013-05-28 | Japan As Represented By Director General Of National Rehabilitation Center For Persons With Disabilities | Method of cdna synthesis |
CA2531451A1 (en) | 2003-06-23 | 2005-01-06 | Epigenomics Ag | Methods and nucleic acids for analyses of colorectal cell proliferative disorders |
DE10338308B4 (de) | 2003-08-15 | 2006-10-19 | Epigenomics Ag | Verfahren zum Nachweis von Cytosin-Methylierungen in DNA |
KR20110138418A (ko) | 2003-10-09 | 2011-12-27 | 에피제노믹스 아게 | 중아황산염을 활용한 디엔에이의 전환방법 |
DE602004030430D1 (de) | 2004-06-23 | 2011-01-20 | Epigenomics Ag | Verfahren zur Quantifizierung von methylierter DNS |
GB2424946A (en) * | 2005-04-05 | 2006-10-11 | Stratec Biomedical Systems Ag | A detection system for substance binding using up-converting fluorescent probes |
EP2529026B1 (en) * | 2010-01-25 | 2013-11-13 | Rd Biosciences Inc. | Self-folding amplification of target nucleic acid |
EP2531608B1 (en) * | 2010-02-05 | 2020-08-19 | Siemens Healthcare Diagnostics Inc. | Methods for increasing multiplex level by externalization of passive reference in polymerase chain reactions |
ES2623859T3 (es) * | 2010-03-04 | 2017-07-12 | Miacom Diagnostics Gmbh | FISH múltiple mejorada |
WO2012162161A1 (en) * | 2011-05-20 | 2012-11-29 | Phthisis Diagnostics | Microsporidia detection system and method |
-
2006
- 2006-04-17 ES ES06750657T patent/ES2382746T3/es active Active
- 2006-04-17 AT AT06750657T patent/ATE547537T1/de active
- 2006-04-17 DK DK06750657.6T patent/DK1871912T3/da active
- 2006-04-17 EP EP11009406A patent/EP2481810A1/en not_active Withdrawn
- 2006-04-17 EP EP06750657A patent/EP1871912B1/en active Active
- 2006-04-17 AU AU2006236363A patent/AU2006236363B2/en active Active
- 2006-04-17 PL PL06750657T patent/PL1871912T3/pl unknown
- 2006-04-17 JP JP2008506828A patent/JP5133238B2/ja not_active Expired - Fee Related
- 2006-04-17 SI SI200631314T patent/SI1871912T1/sl unknown
- 2006-04-17 PT PT06750657T patent/PT1871912E/pt unknown
- 2006-04-17 CA CA2603815A patent/CA2603815C/en active Active
- 2006-04-17 WO PCT/US2006/014667 patent/WO2006113770A1/en active Application Filing
- 2006-04-17 US US11/910,887 patent/US10731215B2/en active Active
-
2012
- 2012-03-05 JP JP2012048559A patent/JP5674696B2/ja active Active
- 2012-05-11 CY CY20121100439T patent/CY1112852T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
ATE547537T1 (de) | 2012-03-15 |
CA2603815C (en) | 2017-09-26 |
JP5674696B2 (ja) | 2015-02-25 |
SI1871912T1 (sl) | 2012-06-29 |
JP2012105679A (ja) | 2012-06-07 |
PT1871912E (pt) | 2012-05-25 |
CA2603815A1 (en) | 2006-10-26 |
PL1871912T3 (pl) | 2012-07-31 |
ES2382746T3 (es) | 2012-06-13 |
JP2008537888A (ja) | 2008-10-02 |
AU2006236363A8 (en) | 2009-03-05 |
EP1871912B1 (en) | 2012-02-29 |
JP5133238B2 (ja) | 2013-01-30 |
EP1871912A1 (en) | 2008-01-02 |
AU2006236363A1 (en) | 2006-10-26 |
AU2006236363B2 (en) | 2012-11-01 |
EP2481810A1 (en) | 2012-08-01 |
DK1871912T3 (da) | 2012-05-14 |
US10731215B2 (en) | 2020-08-04 |
WO2006113770A1 (en) | 2006-10-26 |
US20110059432A1 (en) | 2011-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1112852T1 (el) | Μεθοδος προσδιορισμου της μεθυλιωσης dνα σε δειγματα αιματος ή ουρων | |
DK1721992T3 (da) | Fremgangsmåder og nukleinsyrer til analyser af cellulære proliferative sygdomme | |
EA201170933A1 (ru) | Анализ нуклеиновых кислот, полученных из единичных клеток | |
JP2019528704A5 (el) | ||
DK1421211T3 (da) | Fremgangsmåder til detektion af DNA, som stammer fra forskellige individer | |
DE602005009324D1 (de) | Methode zur Krebsdiagnose mittels Nachweis von DNA und RNA im Kreislauf | |
DE60332948D1 (de) | Strategien zur genexpressionsanalyse | |
SI1871901T1 (sl) | Elitni dogodek A5547-127 ter postopki in kompleti za identificiranje takega dogodka v bioloških vzorcih | |
DE60333295D1 (de) | Verfahren zum nachweis abnormal methylierter nukleinsäure in heterogenen biologischen proben | |
CY1114107T1 (el) | Συνθεσεις και μεθοδοι για την ανιχνευση ιικων ειδικων πυρηνικων οξεων σε ουρα | |
ATE408032T1 (de) | Esr1 und gebärmutterhalskrebs | |
WO2006128140A3 (en) | Gene methylation and expression | |
EP1838867A4 (en) | APOLIPOPROTEIN A-II ISOFORM USED AS BIOMARKER FOR PROSTATE CANCER | |
GB0500996D0 (en) | Detection method and materials therefor | |
DE602005020592D1 (de) | Cpg-amplicon und array-protokoll | |
WO2006116016A3 (en) | Molecular determinants of egfr kinase inhibitor response in glioblastoma | |
ATE491809T1 (de) | Amplifikation von dna-fragmenten | |
WO2009019370A3 (fr) | Procede de dosage de l'apolipoproteine aii pour le diagnostic in vitro du cancer colorectal | |
EP1950289A4 (en) | METHOD FOR COLLECTING DNA FROM A BIOLOGICAL SAMPLE | |
BR0314155A (pt) | Métodos para diagnosticar câncer cervical | |
ATE393242T1 (de) | Verfahren zur identifizierung sulforeduzierender bakterien | |
ATE491041T1 (de) | Verfahren zur quantifizierung von methylierter dns | |
ATE518006T1 (de) | Verfahren zur quantitativen analyse von methylcytosin in dna und verwendungen davon | |
NZ584656A (en) | Mitochondrial dna deletion between about residues 12317-16254 for use in the detection of cancer | |
RU2009146012A (ru) | Способ количественной оценки мутантного аллеля митохондриального генома в лейкоцитах крови человека |